Cargando…

Targeting PI3K and AMPKα Signaling Alone or in Combination to Enhance Radiosensitivity of Triple Negative Breast Cancer

Triple negative breast cancer (TNBC) is the most aggressive breast cancer subtype and is characterized by poor survival. Radiotherapy plays an important role in treating TNBC. The purpose of this study was to determine whether inhibiting the AMP-activated protein kinase (AMPK) and phosphatidylinosit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johnson, Jeremy, Chow, Zeta, Napier, Dana, Lee, Eun, Weiss, Heidi L., Evers, B. Mark, Rychahou, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291172/ https://www.ncbi.nlm.nih.gov/pubmed/32438621 http://dx.doi.org/10.3390/cells9051253

Ejemplares similares

Role of AMPK and Akt in triple negative breast cancer lung colonization
por: Johnson, Jeremy, et al.
Publicado: (2021)

PI3K/mTOR Dual Inhibitor PF-04691502 Is a Schedule-Dependent Radiosensitizer for Gastroenteropancreatic Neuroendocrine Tumors
por: Chow, Zeta, et al.
Publicado: (2021)

Induction of AMPK activation by N,N’-diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers
por: Johnson, Jeremy, et al.
Publicado: (2019)

Radiosensitization with combined use of olaparib and PI-103 in triple-negative breast cancer
por: Jang, Na Young, et al.
Publicado: (2015)

Novel chemotherapeutic agent, FND-4b, activates AMPK and inhibits colorectal cancer cell proliferation
por: Sinner, Heather F., et al.
Publicado: (2019)

Radiation-enhanced therapeutic targeting of galectin-1 enriched malignant stroma in triple negative breast cancer
por: Upreti, Meenakshi, et al.
Publicado: (2016)

Colorectal cancer lung metastasis treatment with polymer–drug nanoparticles
por: Rychahou, Piotr, et al.
Publicado: (2018)

Loss of PHLPP expression in colon cancer: Role in proliferation and tumorigenesis
por: Liu, Jianyu, et al.
Publicado: (2008)

Estrogen Receptor Mediates the Radiosensitivity of Triple-Negative Breast Cancer Cells
por: Chen, Xingxing, et al.
Publicado: (2017)

Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
por: Swanner, Jessica, et al.
Publicado: (2015)

Silencing of XRCC4 increases radiosensitivity of triple-negative breast cancer cells
por: Wen, Yuqing, et al.
Publicado: (2019)

Role of PTEN, PI3K, and mTOR in Triple-Negative Breast Cancer
por: Prvanović, Mirjana, et al.
Publicado: (2021)

Vitamin C sensitizes triple negative breast cancer to PI3K inhibition therapy
por: Mustafi, Sushmita, et al.
Publicado: (2021)

AMPK exerts dual regulatory effects on the PI3K pathway
por: Tao, Rong, et al.
Publicado: (2010)

Proteomic Resistance Biomarkers for PI3K Inhibitor in Triple Negative Breast Cancer Patient-Derived Xenograft Models
por: Guo, Zhanfang, et al.
Publicado: (2020)

Kinase suppressor of Ras 1 and Exo70 promote fatty acid-stimulated neurotensin secretion through ERK1/2 signaling
por: Rock, Stephanie, et al.
Publicado: (2019)

Thioguanine Induces Apoptosis in Triple-Negative Breast Cancer by Regulating PI3K–AKT Pathway
por: Zhang, Daoyu, et al.
Publicado: (2020)

PI3K inhibition enhances the anti-tumor effect of eribulin in triple negative breast cancer
por: Rajput, Sandeep, et al.
Publicado: (2019)

Cyclin D1 is Associated with Radiosensitivity of Triple-Negative Breast Cancer Cells to Proton Beam Irradiation
por: Choi, Changhoon, et al.
Publicado: (2019)

Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway
por: Massihnia, Daniela, et al.
Publicado: (2016)

Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway
por: Xu, Yonggang, et al.
Publicado: (2021)

Abrogating Metastatic Properties of Triple-Negative Breast Cancer Cells by EGFR and PI3K Dual Inhibitors
por: Garcia, Ana Rita, et al.
Publicado: (2023)

PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer
por: Amante, Romain J., et al.
Publicado: (2023)

Spatholobus suberectus inhibits lipogenesis and tumorigenesis in triple-negative breast cancer via activation of AMPK-ACC and K-Ras-ERK signaling pathway
por: Zeng, Xiaohui, et al.
Publicado: (2023)

Inhibition of Fatty Acid Synthase Upregulates Expression of CD36 to Sustain Proliferation of Colorectal Cancer Cells
por: Drury, James, et al.
Publicado: (2020)

SIRT2 Contributes to the Regulation of Intestinal Cell Proliferation and Differentiation
por: Li, Chang, et al.
Publicado: (2020)

The Chk1 inhibitor MK-8776 increases the radiosensitivity of human triple-negative breast cancer by inhibiting autophagy
por: Zhou, Zhi-rui, et al.
Publicado: (2017)

TSC2/mTORC1 signaling controls Paneth and goblet cell differentiation in the intestinal epithelium
por: Zhou, Y, et al.
Publicado: (2015)

Activation of c-Met and Upregulation of CD44 Expression Are Associated with the Metastatic Phenotype in the Colorectal Cancer Liver Metastasis Model
por: Elliott, Victoria A., et al.
Publicado: (2014)

Simultaneous perturbation of the MAPK and the PI3K/mTOR pathways does not lead to increased radiosensitization
por: Kuger, Sebastian, et al.
Publicado: (2015)

Overexpression of IGFBP5 Enhances Radiosensitivity Through PI3K-AKT Pathway in Prostate Cancer
por: Chen, Xue, et al.
Publicado: (2020)

Selective Inhibition of PI3K Isoforms in Brain Tumors Suppresses Tumor Growth by Increasing Radiosensitivity
por: Seol, Mi Youn, et al.
Publicado: (2023)

GPRC5A Is a Negative Regulator of the Pro-Survival PI3K/Akt Signaling Pathway in Triple-Negative Breast Cancer
por: Yang, Lu, et al.
Publicado: (2021)

Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer
por: Solzak, Jeffrey P., et al.
Publicado: (2017)

MAPK4 promotes triple negative breast cancer growth and reduces tumor sensitivity to PI3K blockade
por: Wang, Wei, et al.
Publicado: (2022)

Disulfiram Alone Functions as a Radiosensitizer for Pancreatic Cancer Both In Vitro and In Vivo
por: Xu, Ying, et al.
Publicado: (2021)

MiR-27a Modulates Radiosensitivity of Triple-Negative Breast Cancer (TNBC) Cells by Targeting CDC27
por: Ren, Yong-qiang, et al.
Publicado: (2015)

PRR15 deficiency facilitates malignant progression by mediating PI3K/Akt signaling and predicts clinical prognosis in triple-negative rather than non-triple-negative breast cancer
por: Guo, Fengzhu, et al.
Publicado: (2023)

Radiosensitization of the PI3K inhibitor HS-173 through reduction of DNA damage repair in pancreatic cancer
por: Park, Jung Hee, et al.
Publicado: (2017)

NFAT5 represses canonical Wnt signaling via inhibition of β-catenin acetylation and participates in regulating intestinal cell differentiation
por: Wang, Q, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_pqvbcjjpgq2k8vb7cs3ppt0lg8